At a glance
- Originator Tobishi
- Class
- Mechanism of Action Cholecystokinin A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pancreatitis
Most Recent Events
- 28 Mar 2000 No-Development-Reported for Pancreatitis in Japan (Unknown route)
- 21 Feb 1997 Preclinical development for Pancreatitis in Japan (Unknown route)
- 20 Feb 1997 New profile